Benitez, J. C., et al. Cancer activation pathways of thymic epithelial tumors (TETs) by targeted gene expression analysis. J Clin Oncol 39, 2021 (suppl 15; abstr 8575); 10.1200/JCO.2021.39.15_suppl.8575
Pascual, J., et al. CCNE1 mRNA and cyclin E1 protein expression as predictive biomarkers for efficacy of palbociclib plus fulvestrant versus capecitabine in the phase III PEARL study. J Clin Oncol 39, 2021 (suppl 15; abstr 1014) DOI: 10.1200/JCO.2021.39.15_suppl.1014
David, T., et al. MiRNAs Correlate with Improvement in Disease Activity in Patients with Rheumatoid Arthritis on Tumour Necrosis Factor Inihibitors. Annals of the Rheumatic Diseases 2021;80:409; Poster 0357
Denkert, C., et al. Subgroup of post-neoadjuvant luminal-B tumors assessed by HTG in PENELOPE-B investigating palbociclib in high risk HER2-/HR+ breast cancer with residual disease. J Clin Oncol 39, 2021 (suppl 15; abstr 519) DOI: 10.1200/JCO.2021.39.15_suppl.519
Marmé, F., et al. Palbociclib combined with endocrine treatment in breast cancer patients with high relapse risk after neoadjuvant chemotherapy: Subgroup analyses of premenopausal patients in PENELOPE-B. J Clin Oncol 39, 2021 (suppl 15; abstr 518). DOI 10.1200/JCO.2021.39.15_suppl.518
Jose Antonio Lopez Guerrero, et al. MamaPred: A new and innovative approach to determine recurrence risk in HR+/HER2- early-stage breast cancer using HTG EdgeSeq technology. J Clin Oncol 39, 2021 (suppl 15; abstr 558) DOI 10.1200/JCO.2021.39.15_suppl.558
Desai, J., et al. Potential Mechanisms of Resistance Identified Through Analysis of Multiple biomarkers in Immune-Hot Non-Responders with Non-small Cell Lung Cancer Treated with Tislelizumab. Poster presented at Society for Immunotherapy of Cancer Virtual Congress. 2020 Nov 9-14
Xu, J., et al. Tumor-Immune Signatures Associated with Response or Resistance to Tislelizumab (ANTI-PD1) in Esophageal Squamous Cell Carcinoma (ESCC) Journal for Immunotherapy of Cancer 2020(8)S3:A1-A959
Johnson, K., et al. High-throughput detection of novel circulating miRNA biomarkers of non-alcoholic fatty liver disease. Litmus Project. Consortium Funded by the European Innovative Medicines Initiative.
Anguiano, E., et al. Comparison of gene expression profiling platforms: translatability of tumor inflammation gene signatures. Poster presented at the American Association for Cancer Research (AACR) Virtual Annual Meeting II, 2020 JUN 22-24.
Inaki, K., et al. Pan-cancer gene expression analysis of tissue microarray using EdgeSeq Oncology Biomarker Panel and a cross-comparison with ERBB3 immunohistochemical analysis. Abstract presented at: American Association for Cancer Research (AACR) Virtual Annual Meeting 2020 June 22-24. Online Proceedings. Session PO.MCB09.01 Functional Genomics and Other Topics
Download pdf 1.1MB
View External Link
O'Rourke, D., et al. Comparison of HTG-edge targeted RNA sequencing platform with whole transcriptome RNA sequencing for clinical biomarker studies. Abstract presented at: American Association for Cancer Research (AACR) Virtual Annual Meeting 2020 June 22-24. Online Proceedings. Session PO.CL11.02 Predictive Biomarkers for Treatment Efficacy 1
Download pdf 249KB
View External Link
Page last updated May 22, 2023